Menu Close
Get A Chance To Feature In Magazine By Submitting Your Interview Today!
Tiago M D da Silva | Managing Director | Clinergy Health Research

The Healthcare industry usually faces problems to bridge the gap to solve the problems promptly, and isn’t it something that should be taken care of?

Acknowledging these concerns of filling up the operational gaps and solving the problems in a timely manner, Clinergy Health Research has solutions to a variety of managerial issues while also providing a full revamp of all the health care processes.

Having this problem-solving approach and abundant experience, Tiago M D da Silva, Managing Director, has scientific and management knowledge to enhance the operational experience and deliver superior results.

In an interview with Insights Care, Mr. da Silva talks about Clinergy roles and how it is making a significant difference through its solutions into the healthcare niche.

Please brief our audience about Clinergy Health Research, its USPs, and how it is positioned as a reliable name in the CRO sector?

Clinergy is a CRO, but we always like to highlight that our “C” stands for “Collaborative” rather than “Contract,” and, while for some people, that might look like a small detail, it makes all the difference.

Being a Collaborative Research Organization means that our structure, processes, values, and people are fully focused on long-term value-adding partnerships rather than on short-term transactional relationships with clients.

Such a mindset allows us to truly embrace our client´s vision and ways of working. We act as an extension of their team, focusing on what matters to them while feeling empowered to “run the extra mile” to deliver operational excellence.

This is now more important than ever as we see what has been happing to the CRO environment over the past two decades, with so many mergers and acquisitions resulting in huge CROs with inflated structures (and costs) that surely can still serve a set of substantial clients but no longer fits to serve small biotechs, pharma companies and healthcare start-ups given their very particular needs in terms of costs, flexibility, sense of urgency and attention.

Unlike most CROs, our key driver is not related to short-term financial goals. However, long-term customer satisfaction and we bring that to daily life through the way we shape our KPIs, quality control strategies, and risk-based thinking in everything we do. Another element that

brings our unique mindset to life is the fact that we have made a conscious decision not to have a business development/sales team. Whenever clients reach out to us looking for our services, they get to talk directly with our team of medical doctors, pharmacists, nurses, biologists who will be directly involved in the client´s clinical trial/project, most of whom have been on clinical development for 15, 20+ years.

At the end of the day, science comes first in everything we do so that we can achieve our mission of “helping health innovation reaching patients faster.”

Shed some light on your offerings and how they impact the CRO industry as well as your clients. How your company provides research services to various organizations?

The value we add as strategic partners to our clients is much more a result of our focus on the “how” rather than on the “what.” We are equipped to provide end-to-end planning solutions, conducting and reporting clinical trials from site feasibility and selection to project management, regulatory submissions, risk-based monitoring, data management, statistics, medical writing, among others. However, the means we utilize to deliver are essential.

We are very meticulous when it comes down to understanding what delivery methods can fit each client better so that we can offer cost-effective solutions tailored to each of them without having to choose between cost and efficiency and without trying to push “over the top” solutions only to justify we have them.